174 related articles for article (PubMed ID: 4389858)
1. [Results of the use of a new synthetic antihistaminic (HS 592) in ophthalmology].
Laverone F
Ann Ottalmol Clin Ocul; 1968 Oct; 94(10):1217-24. PubMed ID: 4389858
[No Abstract] [Full Text] [Related]
2. [Case reports in clinical treatment with a synthetic antihistaminic: HS 592].
Giamperi M
Folia Allergol (Roma); 1971; 18(1):69-82. PubMed ID: 4397373
[No Abstract] [Full Text] [Related]
3. [Therapeutic evaluation of a new antihistaminic: HS-592].
Guimarães NA; Fonseca O
Hospital (Rio J); 1968 Nov; 74(5):1511-4. PubMed ID: 4388711
[No Abstract] [Full Text] [Related]
4. A new antihistamine in the treatment of allercig disease.
Basomba A; Oehling A
Allerg Asthma (Leipz); 1969; 15(1):54-60. PubMed ID: 4391901
[No Abstract] [Full Text] [Related]
5. [A new antihistaminic in the treatment of allergic diseases].
Basomba A; Oehling A
Rev Clin Esp; 1968 Jun; 109(5):417-22. PubMed ID: 4391259
[No Abstract] [Full Text] [Related]
6. A new antihistaminic drug (Tavegyl) in allergic diseases.
Hajós M
Ther Hung; 1971; 19(2):67-9. PubMed ID: 4152119
[No Abstract] [Full Text] [Related]
7. [Clinical and allergological evaluation of Tavegil (HS-592), a new antihistaminic drug].
Bogdaszewska-Czabanowska ; Starzycki Z
Przegl Dermatol; 1969; 56(5):659-65. PubMed ID: 4391299
[No Abstract] [Full Text] [Related]
8. [Pharmacological studies on the new antihistaminic Tavegil].
Römer D; Weidmann H
Med Welt; 1966 Dec; 51():2791-4. PubMed ID: 4382572
[No Abstract] [Full Text] [Related]
9. [Clinical evaluation of the antihistaminic activity of a new antihistaminic product with selective and non hypnotic action (HS 592)].
De Caro L; Rizzo SC
Folia Allergol (Roma); 1969; 16(3):234-48. PubMed ID: 4397213
[No Abstract] [Full Text] [Related]
10. [Treatment of allergic eye diseases].
Conradi IS
Tidsskr Nor Laegeforen; 1979 Nov; 99(32):1666-7. PubMed ID: 531849
[No Abstract] [Full Text] [Related]
11. [Clinical analysis using a new antihistaminics (HS-592)].
Lahoz F; Marín F; Sastre A; Pérez Guerrero J
Rev Clin Esp; 1969 Jan; 112(2):175-82. PubMed ID: 4388802
[No Abstract] [Full Text] [Related]
12. [Contribution to the clinical study of HS-592 in allergic manifestations].
da Rocha JM
Hospital (Rio J); 1969 Jan; 75(1):313-5. PubMed ID: 4387990
[No Abstract] [Full Text] [Related]
13. [Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial].
Eberhartinger C; Ebner H
Wien Med Wochenschr; 1969 Sep; 119(38):630-2. PubMed ID: 4390510
[No Abstract] [Full Text] [Related]
14. [Antihistaminic-corticoid combinations in allergy].
Basomba Riba A; García Villalmanzo I; Baguena Candela J
Rev Clin Esp; 1973 Dec; 131(6):491-500. PubMed ID: 4149906
[No Abstract] [Full Text] [Related]
15. [Clinical trial of a new synthetic antihistaminic: HS-592].
Ruiz Moreno G; Del Intento EG; Rossi EA
Prensa Med Argent; 1969 Oct; 56(32):1550-5. PubMed ID: 4396851
[No Abstract] [Full Text] [Related]
16. [Histryl--a new antihistaminic drug].
Bernhardt E
Przegl Dermatol; 1969; 56(4):501-3. PubMed ID: 4390954
[No Abstract] [Full Text] [Related]
17. [Clinical experience with a new antihistaminic].
Wolfram S
Wien Med Wochenschr; 1967 Sep; 117(38):868-70. PubMed ID: 4385553
[No Abstract] [Full Text] [Related]
18. [Observations on the use in ophthalmology of a new antibiotic: staphylomycin].
Miorin G
Minerva Oftalmol; 1966; 8(5):175-8. PubMed ID: 4867305
[No Abstract] [Full Text] [Related]
19. [Considerations on the therapy of spring conjunctivitis].
Genovesi E
Ann Ottalmol Clin Ocul; 1968 Apr; 94(4):393-404. PubMed ID: 4387746
[No Abstract] [Full Text] [Related]
20. [Utilization of new antihistaminic medication in the infant and child: HS 592].
Carron R; Michel M
Lyon Med; 1967 Sep; 218(36):361-4. PubMed ID: 4390427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
